DK130619C - - Google Patents

Info

Publication number
DK130619C
DK130619C DK224361A DK224361A DK130619C DK 130619 C DK130619 C DK 130619C DK 224361 A DK224361 A DK 224361A DK 224361 A DK224361 A DK 224361A DK 130619 C DK130619 C DK 130619C
Authority
DK
Denmark
Application number
DK224361A
Other languages
Danish (da)
Other versions
DK130619B (da
Inventor
H Eikermann
G Lappe
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of DK130619B publication Critical patent/DK130619B/da
Application granted granted Critical
Publication of DK130619C publication Critical patent/DK130619C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/103—Extraction or purification by physical or chemical treatment of natural phosphatides; Preparation of compositions containing phosphatides of unknown structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK224361AA 1960-12-05 1961-06-01 Fremgangsmåde til fremstilling af vandopløselige alfa-tocopherol-lecitin-desoxycholsyreforbindelser. DK130619B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEN19273A DE1141639B (de) 1960-12-05 1960-12-05 Verfahren zur Herstellung wasserloeslicher Cholinphosphorsaeure-diglyceridester-Verbindungen

Publications (2)

Publication Number Publication Date
DK130619B DK130619B (da) 1975-03-17
DK130619C true DK130619C (e) 1975-08-25

Family

ID=7340822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK224361AA DK130619B (da) 1960-12-05 1961-06-01 Fremgangsmåde til fremstilling af vandopløselige alfa-tocopherol-lecitin-desoxycholsyreforbindelser.

Country Status (9)

Country Link
US (1) US3197368A (e)
BE (1) BE610853A (e)
CH (1) CH423766A (e)
DE (1) DE1141639B (e)
DK (1) DK130619B (e)
FR (1) FR1643M (e)
GB (1) GB953899A (e)
NL (2) NL126750C (e)
SE (1) SE310977B (e)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
DE3047048A1 (de) 1980-12-13 1982-07-29 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur abtrennung von oel und/oder phosphatidylethanolamin aus diese enthaltenden alkoholloeslichen phosphatidylcholin-produkten
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
US4649155A (en) * 1983-07-22 1987-03-10 Hoffmann-La Roche Inc. Injectable solutions
US4866044A (en) * 1985-07-09 1989-09-12 Takeda Chemical Industries, Ltd. Solubilized composition of poorly-soluble pharmaceutical product
JPS62106018A (ja) * 1985-11-01 1987-05-16 Santen Pharmaceut Co Ltd 高濃度ビタミンｅ水性製剤
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US20030017528A1 (en) * 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) * 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
US20030180813A1 (en) * 2000-12-01 2003-09-25 Takahide Ohishi Method of screening remedy for diabetes
CA2489405A1 (en) * 2002-09-11 2004-03-25 Yamanouchi Pharmaceutical Co., Ltd. Screening method of agents for increasing insulin content
EP1898931B1 (en) * 2005-07-07 2014-12-31 Postech Foundation Glucose uptake modulator and method for treating diabetes or diabetic complications
US8314080B2 (en) 2010-04-06 2012-11-20 Kuwait University Method of treating type I diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2055083A (en) * 1932-07-13 1936-09-22 Winthrop Chem Co Inc Pharmaceutical preparation

Also Published As

Publication number Publication date
GB953899A (en) 1964-04-02
US3197368A (en) 1965-07-27
CH423766A (de) 1966-11-15
DE1141639B (de) 1962-12-27
DK130619B (da) 1975-03-17
NL126750C (e)
SE310977B (e) 1969-05-19
BE610853A (e)
FR1643M (fr) 1963-01-07
NL260444A (e)

Similar Documents

Publication Publication Date Title
NL260444A (e)
BE665363A (e)
BE588555A (e)
BE598272A (e)
BE599277A (e)
BE601582A (e)
BE602391A (e)
BE603032A (e)
BE603337A (e)
BE603543A (e)
BE603645A (e)
BE603659A (e)
BE604225A (e)
BE604516A (e)
BE604732A (e)
BE604778A (e)
BE604885A (e)
BE604940A (e)
BE605319A (e)
BE605708A (e)
BE606009A (e)
BE606040A (e)
BE606111A (e)
BE606275A (e)
BE606303A (e)